Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Clene (CLNN) Research & Development (2020 - 2025)

Clene has reported Research & Development over the past 6 years, most recently at $5.5 million for Q4 2025.

  • Quarterly results put Research & Development at $5.5 million for Q4 2025, down 1.17% from a year ago — trailing twelve months through Dec 2025 was $14.0 million (down 30.15% YoY), and the annual figure for FY2025 was $14.0 million, down 30.15%.
  • Research & Development for Q4 2025 was $5.5 million at Clene, up from $3.5 million in the prior quarter.
  • Over the last five years, Research & Development for CLNN hit a ceiling of $9.5 million in Q4 2021 and a floor of $1.5 million in Q1 2025.
  • Median Research & Development over the past 5 years was $6.2 million (2021), compared with a mean of $6.1 million.
  • Biggest five-year swings in Research & Development: skyrocketed 113.81% in 2021 and later tumbled 74.77% in 2025.
  • Clene's Research & Development stood at $9.5 million in 2021, then dropped by 18.4% to $7.8 million in 2022, then fell by 14.13% to $6.7 million in 2023, then dropped by 16.56% to $5.6 million in 2024, then dropped by 1.17% to $5.5 million in 2025.
  • The last three reported values for Research & Development were $5.5 million (Q4 2025), $3.5 million (Q3 2025), and $3.5 million (Q2 2025) per Business Quant data.